Dr. Abdulwasiu Bolaji Tiamiyu, Deputy Director of Research in Nigeria, in November graduated from the Harvard Medical School Global Clinical Scholars Training (GCSRT), an advanced training program research for clinicians and clinician-scientists around the globe.
The one-year GCSRT program focuses on enhancing clinicians’ knowledge and abilities in every stage of the health care research process, from grant-writing to study design to written and oral communication of research findings. About 300 students completed this year’s program, which is globally accessible through a blended-learning model that features online and webinar components.
The course culminates with the defense of a capstone project. Dr. Tiamiyu’s project was a randomized, controlled trial to compare the effectiveness of two types of central venous line catheters in preventing blood stream infections. After a rigorous peer review, Dr. Timaiyu’s capstone project was ranked third in this year’s GCSRT cohort.
Dr. Tiamiyu is an HJFMRI research physician supporting WRAIR’s Emerging Infectious Diseases Branch (EIDB) at the Clinical Research Centre in Abuja, Nigeria. Among other EIDB research, Dr. Tiamiyu is involved with two ongoing Lassa virus epidemiology studies, a Phase 2/3 Lassa vaccine trial and a planned Phase 3 COVID vaccine efficacy study.
EIDB supported partially supported this training, EIDB Director Dr. Kayvon Modjarrad, who has served as a mentor for Dr. Tiamiyu, said, “Dr. Tiamiyu has been an integral member of the EIDB team. We, in EIDB, are so proud of his participation and recognition in this course. I know he will use the knowledge he’s gained to advance our mission to counter the most pressing infectious threats in West Africa.”
“EIDB has invested in building local research expertise by supporting training for in-country scientists and researchers,” said Dr. Tiamiyu. “Advanced training like GCRST will help us fulfill the research mission and put us in a better position to study regional infectious disease threats.”